{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:10:56Z","timestamp":1789722656321,"version":"4.0.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"University of Colorado Linda Crnic Institute"},{"DOI":"10.13039\/100008086","name":"Global Down Syndrome Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008086","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Anna and John J. Sie Foundation"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jdcr.2019.02.007","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T17:57:59Z","timestamp":1554487079000},"page":"365-367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata"],"prefix":"10.1016","volume":"5","author":[{"given":"Angela L.","family":"Rachubinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda Enriquez","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory A.","family":"Dunnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Boldrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin M.","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jdcr.2019.02.007_bib1","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2230.2006.02164.x","article-title":"Dermatological manifestations of Down's syndrome","volume":"31","author":"Madan","year":"2006","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.jdcr.2019.02.007_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5070\/D38JX5F2V2","article-title":"Phenotypic and dermatological manifestations in Down Syndrome","volume":"17","author":"Sureshbabu","year":"2011","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jdcr.2019.02.007_bib3","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.16220","article-title":"Trisomy 21 consistently activates the interferon response","volume":"5","author":"Sullivan","year":"2016","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.jdcr.2019.02.007_bib4","doi-asserted-by":"crossref","first-page":"14818","DOI":"10.1038\/s41598-017-13858-3","article-title":"Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation","volume":"7","author":"Sullivan","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.jdcr.2019.02.007_bib5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.autrev.2014.10.014","article-title":"The autoimmune basis of alopecia areata: a comprehensive review","volume":"14","author":"Islam","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.jdcr.2019.02.007_bib6","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000065859","article-title":"An updated survey on skin conditions in Down syndrome","volume":"205","author":"Schepis","year":"2002","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.jdcr.2019.02.007_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5070\/D305M5F4BX","article-title":"Psoriasis and Down syndrome: a report of three cases and a potential pathophysiologic link","volume":"18","author":"Marmon","year":"2012","journal-title":"Dermatol Online J"},{"issue":"1","key":"10.1016\/j.jdcr.2019.02.007_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nrrheum.2009.237","article-title":"Type I interferons: crucial participants in disease amplification in autoimmunity","volume":"6","author":"Hall","year":"2010","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.jdcr.2019.02.007_bib9","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jaad.2016.12.004","article-title":"Janus kinase inhibitors in dermatology: A systematic review","volume":"76","author":"Shreberk-Hassidim","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.jdcr.2019.02.007_bib10","doi-asserted-by":"crossref","first-page":"ii111","DOI":"10.1136\/annrheumdis-2012-202576","article-title":"Janus kinase inhibitors in autoimmune diseases","volume":"72","author":"O'Shea","year":"2013","journal-title":"Ann Rheum Dis"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512619300591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512619300591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:20:19Z","timestamp":1762474819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512619300591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S2352512619300591"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2019.02.007","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2019.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}